FUJIFILM Corporation announced today that it will invest approximately 9 billion yen ($83M USD) to expand the microbial production capacity of FUJIFILM Diosynth Biotechnologies (FDB). It will triple FDB’s current capacity of microbial production at the United Kingdom site. The expansion will include a new production line equipped with 2 X 2000L fermenters and a modular purification suite. Source: Fujifilm press release 18/3/2021